Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kindstar Globalgene Technology Inc stock PB Ratio (=0.33) is close to 5-year low of 0.32.
The historical rank and industry rank for Kindstar Globalgene Technology's PB Ratio or its related term are showing as below:
HKSE:09960'
s PB Ratio Range Over the Past 10 Years
Min: 0.32 Med: 0.47 Max: 1.7
Current: 0.34
During the past 8 years, Kindstar Globalgene Technology's highest PB Ratio was 1.70. The lowest was 0.32. And the median was 0.47.
HKSE:09960's PB Ratio is ranked better than 96.39% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.1
vs HKSE:09960: 0.34
During the past 12 months, Kindstar Globalgene Technology's average Book Value Per Share Growth Rate was -4.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -4.70% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Kindstar Globalgene Technology was -4.70% per year. The lowest was -6.20% per year. And the median was -5.45% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Kindstar Globalgene Technology PB Ratio Related Terms
Kindstar Globalgene Technology PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kindstar Globalgene Technology PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's PB Ratio distribution charts can be found below:
* The bar in red indicates where Kindstar Globalgene Technology's PB Ratio falls into.
Kindstar Globalgene Technology PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Kindstar Globalgene Technology (HKSE:09960) has a PB Ratio of 0.34 as of Aug. 31, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Kindstar Globalgene Technology and its competitors. This is 28% below median its historical median of 0.47. Over the past decade, Kindstar Globalgene Technology's PB Ratio has ranged from 0.32 to 1.70. According to the industry distribution chart, Kindstar Globalgene Technology ranks #7 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 3.6%.
Is Kindstar Globalgene Technology's PB Ratio too high?
Kindstar Globalgene Technology's current PB Ratio of 0.34 is 28% below median its 10-year median of 0.47. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 1.70. The Medical Diagnostics & Research industry median PB Ratio is 2.10. Kindstar Globalgene Technology's value of 0.34 is 83.8% below this industry median. Based on the distribution chart, Kindstar Globalgene Technology ranks #7 out of 194 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Kindstar Globalgene Technology has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kindstar Globalgene Technology's PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Kindstar Globalgene Technology ranks #7 out of 194 companies for PB Ratio. This places Kindstar Globalgene Technology in the top 4% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.10. Kindstar Globalgene Technology's value of 0.34 is 83.8% below this benchmark. Historically, Kindstar Globalgene Technology's own PB Ratio has ranged from 0.32 to 1.70 over the past decade. While the company's 10-year median is 0.47 vs. the industry median of 2.10, Kindstar Globalgene Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.10, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kindstar Globalgene Technology's current PB Ratio of 0.34 is 83.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Kindstar Globalgene Technology and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kindstar Globalgene Technology's current PB Ratio is 0.34, which is 28% below median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kindstar Globalgene Technology stock overvalued right now?
Based on GuruFocus' analysis, Kindstar Globalgene Technology (HKSE:09960) is currently considered Fairly Valued. The stock's GF Value™ is HK$1.06, compared to a current price of HK$1.00 — trading 5.7% below its estimated fair value. The current PB Ratio is 0.34, which is 28% below median its 10-year median of 0.47 and 83.8% below the Medical Diagnostics & Research industry median of 2.10. Kindstar Globalgene Technology's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Kindstar Globalgene Technology (HKSE:09960), the current PB Ratio is 0.34 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kindstar Globalgene Technology (HKSE:09960) Overvalued in 2026?
Based on GuruFocus' analysis, Kindstar Globalgene Technology stock appears to be undervalued.
The current stock price of HK$1.00 is trading 5.7% below its estimated GF Value™ of HK$1.06.
GuruFocus considers Kindstar Globalgene Technology to be Fairly Valued.
Key valuation signals for HKSE:09960:
PB Ratio: 0.34 (28% below median its 10-year median of 0.47)
GF Value™: HK$1.06 vs. price of HK$1.00 (5.7% below fair value)
Industry Position: 83.8% below the Medical Diagnostics & Research median (#7 of 194)
No single metric tells the full story. See the HKSE:09960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kindstar Globalgene Technology Inc is engaged in the provision of clinical testing services in China. It operates in nine segments: Hematology testing segment includes testing services related to blood diseases; Genetic diseases and rare diseases segment includes testing services for rare diseases; Infectious diseases segment includes testing services from the infection department; Oncology segment includes testing related to oncology diseases; Neurology segment includes testing services related to neurological diseases undertaken by the Group; Maternity-related diseases segment includes testing services related to maternity; Routine testing segment conducts routine tests for the doctors daily diagnoses; CROs & R&D project segment includes research & develop services; & others segment.
69GF Score
Get the complete analysis for HKSE:09960
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09960 has been successfully added to your 
